Clicky

Laboratory Corporation of America Holdings(LH)

Description: Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It offers a range of clinical laboratory tests, including blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company provides clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of diseases. It also offers specialty testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics, cardiovascular disease risk assessment, clinical trials, allergy, women's health, identity, forensics, infectious disease, and occupational testing. The company provides its services through a sales force to the physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. It operates a national network of 50 primary laboratories and approximately 1,800 patient service centers, as well as branches and STAT laboratories. Laboratory Corporation of America Holdings has collaboration with university, hospital and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. The company was founded in 1971 and is headquartered in Burlington, North Carolina.


Keywords: Medicine Pharmaceutical S&P 500 Life Sciences Disease Infectious Diseases Allergy Cardiovascular Disease HIV Medical Test Diagnostic Tests Blood Test HIV/Aids Medical Laboratory Genotyping HCV Diagnosis Of Hiv/Aids Johns Hopkins University Innogenetics The Johns Hopkins University University Of Minnesota

Home Page: www.labcorp.com

LH Technical Analysis

358 South Main Street
Burlington, NC 27215
United States
Phone: 336 229 1127


Officers

Name Title
Mr. Adam H. Schechter Pres, CEO & Chairman
Mr. Glenn A. Eisenberg CFO & Exec. VP
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH Exec. VP, Pres of Diagnostics & Chief Medical Officer
Mr. Mark S. Schroeder Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain
Dr. Paul R. Kirchgraber M.D. Exec. VP & CEO of Covance Drug Devel.
Dr. Michelle Abelson Ph.D. Laboratory Director of Operations
Mr. Peter J. Wilkinson Sr. VP & Chief Accounting Officer
Mr. Lance V. Berberian Exec. VP and Chief Information & Technology Officer
Dr. Marcia T. Eisenberg Ph.D. Chief Scientific Officer & Sr. VP
Chas Cook VP of Investor Relations

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 12.7877
Trailing PE: 12.8175
Price-to-Book MRQ: 2.0246
Price-to-Sales TTM: 1.3314
IPO Date: 1990-03-29
Fiscal Year End: December
Full Time Employees: 75000
Back to stocks